Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Øystein Fodstad<br>Scientific director
Øystein Fodstad
Scientific director

Scientific production - Institute for Cancer Research

  PubMed articles Doctoral theses
2010 so far so far
2009 164 22
2008 140 11
2007 153 16
2006 171 12
2005 158 12

Department overview

 

Latest news

University of Oslo's Research Prize to Johan Moan

 
J. Moan
J. Moan

This year's research prize from the University of Oslo goes to professor Johan Moan from the Department of Radiation Biology at the Institute for Cancer Research.
The prize amounts to NOK 250.000, and will be awarded during UiO's annual banquet on September 2nd.

 
 

JAMA article first-authored by Philip Wilkens

 
P. Wilkens
P. Wilkens

A study performed by research fellow and chiropractor Philip Wilkens from the orthopaedic centre at the Division of Surgery and Clinical Neuroscience confirms that glucosamine has no relieving effect on backache. The findings attract international attention, and are published in the prestigious journal "Journal of American Medical Association" (JAMA) (journal impact factor 31,7). The article - entitled "Effect of Glucosamine on Pain-related Disability in Patients with Chronic Low Back Pain and Degenerative Lumbar Osteoarthritis: A Randomized Controlled Trial" - is published in the July 7th issue of JAMA.

 
 

Sir Hans Krebs Medal to Harald Stenmark

 
HA Stenmark
HA Stenmark

At the 2010 FEBS Congress in Gothenburg, Harald Stenmark from the Centre for Cancer Biomedicine and the Institute for Cancer Research was awarded the Sir Hans Krebs Medal. This medal is awarded annually by the Federation of European Biochemical Societies for "outstanding achievements in Biochemistry and Molecular Biology or related sciences". Recent awardees include Nobel laureates Aaron Ciechanover (2006) and Tim Hunt (2008). After receiving the medal, Stenmark presented a plenary lecture entitled "How a lipid mediates tumour suppression".